Accessibility Accessibility icon
CONSULTATION (303) 951-5829
Accent Image
Introducing the new ThermiFill procedure for Lip Rejuvenation

Introducing the new ThermiFill procedure for Lip Rejuvenation

Introducing the new ThermiFill procedure for Lip Rejuvenation

January 30, 2016

One of the most challenging things to address in facial aging are those annoying lip lines that form as the result of not only smoking but also just the aging process itself.  In the past, our go-to procedure for this area has been laser resurfacing.  But while the results have been good, they have also been associated with several weeks of downtime which many of our patients simply aren’t willing to accept.  Until now…

At BEAUTY by BUFORD, we are proud to announce the new ThermiFill procedure for lip rejuvenation.  This innovative new technique combines the power of ThermiTight followed by administration of Juvederm Ultra XC to restore elasticity to this area and fill in those pesky wrinkles that, until now, have been challenging to address.  The procedure begins with a 30 minute ThermiTight procedure performed in the office using locally instilled numbing solution.  Through tiny openings on either side of the lip, the ThermiTight cannula is inserted into the white tissue above and below the lips and the radio frequency energy is then used to effectively stimulate collagen re-organization and re-alignment.  Heat is administered in a precise and controlled manner to heat up the tissue and stimulate a local wounding response to which your body responds by stimulating growth of new collagen.  The cannula is then removed and Juvederm Ultra XC is injected into the fine lines above and below your lips to plump out the wrinkles during this initial period of collagen stimulation.  This secondary procedure is intended to provide temporary volume which will then bridge the gap between the initial time of treatment and the time to collagen stimulus when your body will effectively replace this temporary product with your own volume matrix.

For those patients susceptible to peri-oral cold sores, prophylactic medicine will be administered in addition to a light pain medication, as needed.

We are excited to introduce you to this innovative new procedure and look forward to your questions, comments, and insights.  To see if you would be a good candidate, we encourage you to email a photo of your lips to melanie@beautybybuford.com.  We will review your photo and let you know if we feel that this procedure would be effective for you!  For any questions, we encourage you to call us at 303.747.6719.

Thank you again for your continued support.  We look forward to working with you!

Visualize your NEW LOOK in 3D NOW

START NOW
Natrelle® Breast Implants
IMPORTANT SAFETY INFORMATION

Breast implants are not lifetime devices. The longer patients have them, the greater the chance they will develop complications, which may require more surgery. Breast implants have been associated with a cancer of the immune system called breast implant–associated anaplastic large cell lymphoma (BIA-ALCL). Some patients have died from BIA-ALCL. Patients have also reported a variety of systemic symptoms such as joint pain, muscle aches, confusion, chronic fatigue, autoimmune diseases, and others.

Natrelle® Breast Implants are for breast augmentation and revision surgery in women at least 22 years old for silicone-filled implants and women at least 18 years old for saline-filled implants.

You should not get breast implants if you currently have an active infection, untreated breast cancer or precancer, or are pregnant or nursing. Tell your doctor about any conditions you have, any medications you are taking, and any planned cancer treatments. Breast implantation is likely not a one-time surgery.

Having implants removed and not replaced may lead to permanent cosmetic changes of the breasts. Breast implants may affect breastfeeding. Gel implants may rupture without symptoms, so periodic imaging after surgery is recommended.

Key complications are reoperation, implant removal, implant rupture, implant deflation with saline-filled implants, and severe capsular contracture.

Talk to your doctor for more information.

The use of Natrelle® Breast Implants is restricted to licensed physicians who provide information to patients about the risks and benefits of breast implant surgery.

Visualize your
NEW LOOK in 3D NOW!

Start now
START NOW
Natrelle® Breast Implants
IMPORTANT SAFETY INFORMATION

Breast implants are not lifetime devices. The longer patients have them, the greater the chance they will develop complications, which may require more surgery. Breast implants have been associated with a cancer of the immune system called breast implant–associated anaplastic large cell lymphoma (BIA-ALCL). Some patients have died from BIA-ALCL. Patients have also reported a variety of systemic symptoms such as joint pain, muscle aches, confusion, chronic fatigue, autoimmune diseases, and others.

Breast implants are not lifetime devices. The longer patients have them, the greater the chance they will develop complications, which may require more surgery. Breast implants have been associated with a cancer of the immune system called breast implant–associated anaplastic large cell lymphoma (BIA-ALCL). Some patients have died from BIA-ALCL. Patients have also reported a variety of systemic symptoms such as joint pain, muscle aches, confusion, chronic fatigue, autoimmune diseases, and others.

Breast implants are not lifetime devices. The longer patients have them, the greater the chance they will develop complications, which may require more surgery. Breast implants have been associated with a cancer of the immune system called breast implant–associated anaplastic large cell lymphoma (BIA-ALCL). Some patients have died from BIA-ALCL. Patients have also reported a variety of systemic symptoms such as joint pain, muscle aches, confusion, chronic fatigue, autoimmune diseases, and others.

Breast implants are not lifetime devices. The longer patients have them, the greater the chance they will develop complications, which may require more surgery. Breast implants have been associated with a cancer of the immune system called breast implant–associated anaplastic large cell lymphoma (BIA-ALCL). Some patients have died from BIA-ALCL. Patients have also reported a variety of systemic symptoms such as joint pain, muscle aches, confusion, chronic fatigue, autoimmune diseases, and others.